Literature DB >> 23129175

Morbidity following thyroid surgery: does surgeon volume matter?

Carmen González-Sánchez1, Guzmán Franch-Arcas, Alberto Gómez-Alonso.   

Abstract

PURPOSE: The aim of our study was to analyze the relationship between surgeon volume and morbidity in patients operated on by surgeons with endocrine specialization (EndS group) and those operated on by general surgeons (GenS group) in a single tertiary institution.
METHODS: We present the results of a prospective cohort study of all patients undergoing thyroid surgery in our institution between January 2008 and January 2010, all of whom attended for follow-up for at least 12 months. We assessed pre- and postoperative recurrent laryngeal nerve (RLN) function by laryngoscopy. We monitored serum calcium concentrations in all patients until these values were normal without vitamin D and oral calcium supplementation.
RESULTS: We studied 225 patients: 30 in the GenS group (six surgeons performing <5 procedures per surgeon per year) and 195 in the EndS group (two surgeons performing >40 procedures per surgeon per year). The total number of exposed RLN was 46 and 325, respectively. The incidence of RLN palsy persisting beyond 12 months was higher in the GenS group (2/46 vs. 1/325 exposed RLNs, p = 0.04). The incidence of hypocalcaemia persisting beyond 12 months (bilateral procedures) was also higher in the GenS group (3/16 vs. 3/130 patients, p = 0.028).
CONCLUSIONS: Morbidity in terms of permanent RLN palsy and hypocalcaemia was less frequent among patients operated on by endocrine-dedicated surgeons. Differences in surgical volume and specialized training in neck endocrine surgery may explain these variations in morbidity.

Entities:  

Mesh:

Year:  2012        PMID: 23129175     DOI: 10.1007/s00423-012-1027-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  6 in total

1.  [Thyroid gland surgery: risk factor surgeon].

Authors:  H Dralle
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  Volume-based trends in thyroid surgery.

Authors:  Christine G Gourin; Ralph P Tufano; Arlene A Forastiere; Wayne M Koch; Timothy M Pawlik; Robert E Bristow
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-12

3.  Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery.

Authors:  Alexandra I Stavrakis; Philip H G Ituarte; Clifford Y Ko; Michael W Yeh
Journal:  Surgery       Date:  2007-10-26       Impact factor: 3.982

4.  The importance of surgeon experience for clinical and economic outcomes from thyroidectomy.

Authors:  J A Sosa; H M Bowman; J M Tielsch; N R Powe; T A Gordon; R Udelsman
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

5.  Quality monitoring in thyroid surgery using the Shewhart control chart.

Authors:  A Duclos; S Touzet; P Soardo; C Colin; J L Peix; J C Lifante
Journal:  Br J Surg       Date:  2009-02       Impact factor: 6.939

6.  Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study.

Authors:  Antoine Duclos; Jean-Louis Peix; Cyrille Colin; Jean-Louis Kraimps; Fabrice Menegaux; François Pattou; Fréderic Sebag; Sandrine Touzet; Stéphanie Bourdy; Nicolas Voirin; Jean-Christophe Lifante
Journal:  BMJ       Date:  2012-01-10
  6 in total
  12 in total

1.  Incidence and risk factors for injuries to the recurrent laryngeal nerve during neck surgery in the moderate-volume setting.

Authors:  Kalle Landerholm; Anna-Maria Wasner; Johannes Järhult
Journal:  Langenbecks Arch Surg       Date:  2014-01-09       Impact factor: 3.445

2.  Surgeon volume and hospital volume in endocrine neck surgery: how many procedures are needed for reaching a safety level and acceptable costs? A systematic narrative review.

Authors:  G Melfa; C Porello; G Cocorullo; C Raspanti; G Rotolo; A Attard; R Gullo; S Bonventre; G Gulotta; G Scerrino
Journal:  G Chir       Date:  2018 Jan-Feb

3.  REFERRAL OF OLDER THYROID CANCER PATIENTS TO A HIGH-VOLUME SURGEON: RESULTS OF A MULTIDISCIPLINARY PHYSICIAN SURVEY.

Authors:  Maria Papaleontiou; Paul G Gauger; Megan R Haymart
Journal:  Endocr Pract       Date:  2017-05-23       Impact factor: 3.443

Review 4.  Accreditation of endocrine surgery units.

Authors:  Thomas J Musholt; Robert Bränström; Reto Martin Kaderli; Nuria Muñoz Pérez; Marco Raffaelli; Michael J Stechman
Journal:  Langenbecks Arch Surg       Date:  2019-09-07       Impact factor: 3.445

Review 5.  Incidence, prevalence and risk factors for post-surgical hypocalcaemia and hypoparathyroidism.

Authors:  Ovie Edafe; Sabapathy Prakash Balasubramanian
Journal:  Gland Surg       Date:  2017-12

6.  Prediction of permanent hypoparathyroidism after total thyroidectomy.

Authors:  M Almquist; P Hallgrimsson; E Nordenström; A Bergenfelz
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

7.  Outpatient Thyroid Surgery in a Low-Surgical Volume Hospital.

Authors:  Marco Antonio Ayala; Myron William Yencha
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

8.  Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).

Authors:  Bruno Niederle; Frédéric Sebag; Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-12-03       Impact factor: 3.445

9.  Recurrent laryngeal nerve management in thyroid surgery: consequences of routine visualization, application of intermittent, standardized and continuous nerve monitoring.

Authors:  Angkoon Anuwong; Matteo Lavazza; Hoon Yub Kim; Che-Wei Wu; Stefano Rausei; Vincenzo Pappalardo; Cesare Carlo Ferrari; Davide Inversini; Andrea Leotta; Antonio Biondi; Feng-Yu Chiang; Gianlorenzo Dionigi
Journal:  Updates Surg       Date:  2016-09-20

10.  THYROID SURGERY, IONM AND SUGAMMADEX SODIUM RELATIONSHIPS: BENEFITS IN SUGAMMADEX SODIUM USE FOR IONM.

Authors:  T Donmez; V M Erdem; O Sunamak; H Ozcevik
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.